IntusCare Gets Major Investment to Scale AI for Senior Care

NEW YORK, NY – April 15, 2026 – IntusCare, a technology firm at the forefront of artificial intelligence in senior healthcare, today announced a majority growth investment from Blue Star Innovation Partners (BSIP). The partnership is set to inject significant capital and operational expertise into scaling IntusCare’s purpose-built platform for the nation's most complex senior care providers, particularly those in the Program of All-Inclusive Care for the Elderly (PACE).

This strategic alliance aims to fortify IntusCare’s position as an essential operating system for a senior care market facing unprecedented demographic pressures. While already on a rapid growth trajectory, the investment from the Frisco, Texas-based growth equity firm will accelerate the development of an end-to-end digital ecosystem designed to break through the operational bottlenecks that have historically constrained the expansion of high-quality, home-based senior care.

Tackling the PACE Bottleneck

The Program of All-Inclusive Care for the Elderly is widely hailed as the “gold standard” for delivering nursing-home-level care to frail seniors in their own homes. This integrated, provider-led model has demonstrated remarkable success in improving health outcomes and reducing costs. Its growth reflects this success; since 2019, enrollment has surged by 69%, and the number of PACE organizations has increased by 45%. With the 200th PACE program opening earlier this year and over 70 new centers in active development, the model is at a critical inflection point.

However, this expansion is hampered by significant challenges. PACE programs operate under a labyrinth of federal and state regulations, creating an intense compliance burden. They must coordinate a vast array of medical and social services through an interdisciplinary team, a process that is often fractured by disparate data systems and manual workflows. These operational and regulatory complexities have created a bottleneck, slowing the growth of a model that is desperately needed as the Medicare-eligible population expands.

An AI-Powered Solution for Complex Care

IntusCare aims to break that bottleneck. The company has developed a differentiated product ecosystem specifically designed for the unique demands of PACE and similar coordinated care models. At its core is CareHub, an electronic medical record (EMR) platform co-designed with PACE leaders to manage the model's intricate clinical, operational, and financial workflows.

Unlike generic EMRs adapted for senior care, IntusCare’s platform was built from the ground up with compliance “baked in.” It combines the ONC-certified EMR with AI-powered automation, advanced data infrastructure, and predictive analytics. This allows organizations to better manage medical risk by proactively identifying at-risk individuals, improve care coordination across the interdisciplinary team, and ensure constant readiness for federal and state audits. By replacing outdated technology and manual workarounds, the platform significantly reduces the administrative burden that diverts resources from direct patient care.

“This partnership represents an important milestone for IntusCare and its ability to impact complex, senior care organizations,” said Robbie Felton, CEO of IntusCare. “From the outset, we were focused on finding a partner who would accelerate our ability to modernize how care is delivered to Medicare and Medicaid-eligible seniors. We wanted a partner who could provide not just capital, but also the understanding of how to scale innovative and high-quality software in a regulated and impact-driven industry. We found that in BSIP.”

The Strategic Investment Fueling National Scale

The partnership with Blue Star Innovation Partners is about more than just capital. BSIP is a growth-focused investment firm that prides itself on being “built by founders, for founders,” bringing deep operational experience from building and scaling software companies, particularly in highly regulated sectors like healthcare.

BSIP’s strategy involves providing hands-on support, deploying a full-time operating team to help its portfolio companies with sales execution, product development, and go-to-market strategy. This operational infrastructure is precisely what’s needed to deploy a compliant, regulated technology platform on a national scale, navigating the state-by-state variations and complex federal rules governing PACE.

“IntusCare is addressing a critical need in the senior care market using AI to align clinical care, operations, compliance, and financial performance in one modern technology platform,” said Dan Wechsler, CEO of Blue Star Innovation Partners. “We’re thrilled to partner with IntusCare as we see significant demand for purpose-built technology supporting senior care providers.”

Shaping the Future of Care for an Aging America

This investment arrives at a crucial moment. The United States is navigating the demographic shift of the “Silver Tsunami,” with the senior population growing at a historic rate. This has placed immense strain on the existing healthcare infrastructure and fueled a booming market for senior care technologies, projected to reach nearly $50 billion within the next decade.

The IntusCare-BSIP partnership exemplifies a powerful trend: the convergence of private equity and advanced technology to build the foundational systems needed for the future of healthcare. It represents a significant bet that AI and purpose-built software can solve the core challenges of scalability and efficiency in value-based care.

For PACE programs, technology is transitioning from a back-office tool to the fundamental engine driving care delivery. The demand is shifting from basic record-keeping systems to interconnected, predictive ecosystems that can automate workflows and provide real-time insights. This investment provides IntusCare with the resources to meet that demand, accelerating the digital transformation of a care model that holds immense promise for improving the lives of millions of aging Americans.